Beijing Fengshangshiji Culture Medi (300860) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Beijing Fengshangshiji Culture Medi stock ¥15.33, price ¥30.36, that is 49.5% below the price, quality 48 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range ¥19.34 – ¥66.54 · fair‑value band ¥10.12 – ¥19.16 · the ¥30.36 price screens above the ¥15.33 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Beijing Fengshangshiji Culture Medi in your weekly email
Every Wednesday you see whether Beijing Fengshangshiji Culture Medi is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Funshine Culture Group Co.,Ltd. engages in the design and production services for cultural performances in China.
Show moreShow less
The company is involved in the cultural celebrations or commemorative events, TV programs, performances, TV cultural evenings, corporate brand cultural activities, and opening and closing ceremonies of sports events; and tourism performances, evening tours, theme parks, cultural tourism complexes, and industrial parks cultural tourism project services.
It also engages in scenic lighting design and production, landscape and architectural artistic lighting design, and landscape and architectural light show; content production, as well as musicals, artist management, music entertainment, and short dramas.
The company was formerly known as Beijing Funshine Culture Media Co., Ltd. and changed its name to Funshine Culture Group Co.,Ltd. in March 2023. Funshine Culture Group Co.,Ltd. was founded in 2002 and is headquartered in Beijing, China.
Stock analysis
Beijing Fengshangshiji Culture Medi (300860) currently trades at ¥30.36, while our model-based Fair Value estimate is ¥15.33, 50% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 94/100, which puts the data coverage at low.
Scenario range: ¥10.12 (bear) to ¥19.16 (bull), the price of ¥30.36 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Communication Services sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Beijing Fengshangshiji Culture Medi reported revenue of 239M CNY in FY2025 versus 467M CNY in FY2021, a compound −15.4%/yr. Reported net income was −16.6M CNY in FY2025.
Key figures
Market cap 5.7B CNY (≈ $858M) Small · P/S ratio 41.3 · EPS (TTM) ¥−0.1800 · Dividend yield 0.7% · Net margin −21.6% · Return on equity −1.1% · Return on assets (EBIT) 1.6% (5-year average) · Operating margin −75.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 15 out of 100 (medium confidence).
What moves the price
The share trades about 11% below its 52-week high and 34% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Communication Services peers we cover trades at −13% fair-value upside, at −50%, 300860 screens richer than that median.
Fair Value models
Bear¥10.12Fair Value ¥15.33Bull¥19.16
Price ¥30.36 · Downside -49.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−58.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−24.7%
Start year 2020 (pandemic). Over 10 years: +12.3% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
34.4% (2020) → −20.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Beijing Fengshangshiji Culture Medi with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Entertainment · 221 stocks
Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside−49.5% · Below median
Profitability
Return on assets−0.5% · Below median
Net margin (12 months)−21.6% · Bottom 25%
Operating margin (12 months)−75.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−80.2% · Bottom 25%
Dividend yield (12 months)0.7% · Bottom 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Entertainment median · lower = cheaper
P/B1.83× · Pricier than median
P/S (12 months)36.76× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 32
FUTURE (revenue growth)0· sector 20
PAST (return on equity)0· sector 5
HEALTH (low debt)100· sector 96
DIVIDEND (yield)14· sector 46
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Beijing Fengshangshiji Culture Medi Fair Value". https://www.fairvalue-calculator.com/stock/300860
Frequently asked questions
Is Beijing Fengshangshiji Culture Medi (300860) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of ¥15.33 versus a price of ¥30.36, about 50% lower (overvalued).
What is the fair value of 300860?
Our model-based fair value for Beijing Fengshangshiji Culture Medi is ¥15.33 (as of Nov 6, 2026), built from audited fundamentals. The current price: ¥30.36.
What is the quality score of 300860?
Beijing Fengshangshiji Culture Medi has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Beijing Fengshangshiji Culture Medi (300860)?
Our model-based price target is the fair value of ¥15.33 (as of Nov 6, 2026) from 1 valuation models. Cautious scenario ¥10.12, optimistic scenario ¥19.16. It is a calculation from audited fundamentals, not an analyst target.
What is the Beijing Fengshangshiji Culture Medi stock forecast for 2026?
Our models put fair value at ¥15.33, about 50% lower versus a price of ¥30.36 (overvalued). Cautious scenario ¥10.12, optimistic scenario ¥19.16. The calculation is refreshed regularly with new filings.
What is the revenue of Beijing Fengshangshiji Culture Medi (300860)?
Beijing Fengshangshiji Culture Medi reported trailing-twelve-month revenue of about 156M CNY (latest available figure, as of Nov 6, 2026).
Does Beijing Fengshangshiji Culture Medi pay a dividend?
Beijing Fengshangshiji Culture Medi currently shows a dividend yield of 0.69% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Beijing Fengshangshiji Culture Medi (300860) and when is the ex-dividend date?
Beijing Fengshangshiji Culture Medi pays a dividend of ¥0.21 per share a year, a dividend yield of 0.7%. The last ex-dividend date was May 26, 2026. Our assessment: Token dividend. At a yield of 0.7% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.7% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Beijing Fengshangshiji Culture Medi (300860)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Beijing Fengshangshiji Culture Medi it is ¥15.33 per share (as of Nov 6, 2026), against a price of ¥30.36. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Beijing Fengshangshiji Culture Medi stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 300860 trades above its calculated fair value: price ¥30.36, fair value ¥15.33, a gap of about −50% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300860?
No. The price is what the market pays today (¥30.36); the fair value is what the company's own numbers justify (¥15.33). For Beijing Fengshangshiji Culture Medi the two are ¥15.03 per share apart. That gap is exactly why we show both numbers side by side.
How much is Beijing Fengshangshiji Culture Medi worth?
The market values Beijing Fengshangshiji Culture Medi at about 5.7B CNY (market capitalisation, as of Nov 6, 2026). Per share that is ¥30.36; our models calculate a fair value of ¥15.33 per share.
What do the bullish and bearish scenarios say about 300860?
Our models span a range for Beijing Fengshangshiji Culture Medi: cautious scenario ¥10.12, base ¥15.33, optimistic ¥19.16 per share (as of Nov 6, 2026, price ¥30.36). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Beijing Fengshangshiji Culture Medi (300860)?
Balance-sheet figures for Beijing Fengshangshiji Culture Medi (as of Nov 6, 2026): return on equity −1.1%, debt of 0.00 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 300860 from its 52-week high?
Beijing Fengshangshiji Culture Medi trades at ¥30.36, about 11% below its 52-week high of ¥34.09 and 34% above the low of ¥22.67 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥15.33 is for.
Which stocks are comparable to Beijing Fengshangshiji Culture Medi?
From the same area (Communication Services) we also value Netflix, Inc, The Walt Disney Company, Live Nation Entertainment, Inc, TKO Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Beijing Fengshangshiji Culture Medi stock attractive at the current price?
The data as of Nov 6, 2026: price ¥30.36, calculated fair value ¥15.33 (−50%), Quality Score 48/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300860 calculated?
We run Beijing Fengshangshiji Culture Medi through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of ¥15.33 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Beijing Fengshangshiji Culture Medi itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Beijing Fengshangshiji Culture Medi (300860)?
The closing price on Nov 6, 2026 was ¥30.36. Our model-based fair value is ¥15.33, about 50% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Beijing Fengshangshiji Culture Medi right now?
The price sits above even our optimistic bull case (¥19.16). The favourable scenario is already priced in. Weak quality (48/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (¥10.12 to ¥19.16) leaves room in how you read the outcome.
Where does the earnings growth of Beijing Fengshangshiji Culture Medi (300860) come from?
Earnings per share at Beijing Fengshangshiji Culture Medi grew +8.8 % a year from 2013 to 2024. Broken into its drivers: revenue per share +8.3 %, EBIT margin −0.8 %, tax rate +1.0 %, residual (interest, one-offs) +0.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Beijing Fengshangshiji Culture Medi
How large is the market capitalisation of Beijing Fengshangshiji Culture Medi (300860)?
The market capitalisation of Beijing Fengshangshiji Culture Medi is 5.7B CNY (≈ $858M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Beijing Fengshangshiji Culture Medi (300860)?
The price-to-sales ratio of Beijing Fengshangshiji Culture Medi is 41.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Beijing Fengshangshiji Culture Medi (300860)?
Earnings per share at Beijing Fengshangshiji Culture Medi are ¥−0.1800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Beijing Fengshangshiji Culture Medi (300860)?
The dividend yield of Beijing Fengshangshiji Culture Medi is 0.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Beijing Fengshangshiji Culture Medi (300860)?
The net margin of Beijing Fengshangshiji Culture Medi is −21.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Beijing Fengshangshiji Culture Medi (300860)?
The return on equity (ROE) of Beijing Fengshangshiji Culture Medi is −1.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Beijing Fengshangshiji Culture Medi (300860)?
On an EBIT basis the return on assets of Beijing Fengshangshiji Culture Medi is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Beijing Fengshangshiji Culture Medi (300860)?
The operating margin of Beijing Fengshangshiji Culture Medi is −75.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Beijing Fengshangshiji Culture Medi (300860)?
Revenue at Beijing Fengshangshiji Culture Medi is growing −80.2% versus a year earlier (3y avg −9.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Beijing Fengshangshiji Culture Medi (300860)?
Earnings per share at Beijing Fengshangshiji Culture Medi are growing −50.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Beijing Fengshangshiji Culture Medi (300860) generate?
The free cash flow of Beijing Fengshangshiji Culture Medi is −44.1M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Beijing Fengshangshiji Culture Medi (300860) hold?
Beijing Fengshangshiji Culture Medi holds more cash than debt, 516M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Beijing Fengshangshiji Culture Medi in the live analysis
One click puts Beijing Fengshangshiji Culture Medi on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 6, 2026